Program
#2 Cancer: Comprehensive GROUP 2.75, 5.03, 15.61, 17.5, 37, 95.5, 200, 434.39, 739.1, 905.31
In 2025, the BeamRay company continued to honor Dr. Royal Rife's legacy by enhancing the original technology, creating Program #2 for their BeamRay Mats. This program, known as the Comprehensive Cancer Group, includes a wide array of frequencies designed to address multiple forms of cancer. The frequencies are specifically chosen to target a range of conditions, from Adrenocortical Cancer to Womb Cancer and everything in between. With frequencies such as 2.75 kHz, 5.03 kHz, 17.5 kHz, and 739.1 kHz, this group of frequencies has been used with great success over the last 15 years in treating a wide variety of cancers. These frequencies were carefully selected based on years of research and testing in line with Dr. Rife's original principles.
The innovative treatment is facilitated through two mats: a white light mat and an infrared light mat, both designed to emit the frequencies through light. The white light mat uses visible light waves, while the infrared mat uses red infrared light waves that penetrate deeper into the tissues. Both mats are equipped with advanced technology to ensure that each frequency is transmitted effectively and accurately. Patients undergoing treatment can place the mats directly on the body at the point of concern, where the frequency can directly interact with the cells. For example, the mat might be placed on the abdomen for digestive system cancers or wrapped around the chest for lung or breast cancers.
The controller for the BeamRay Mats allows the user to set the treatment duration, offering options of 30 minutes, 60 minutes, 90 minutes, or 120 minutes. This flexibility provides the patient with control over their treatment session, allowing for either shorter, more focused treatments or longer sessions for deeper therapeutic effect. The timer ensures consistency in treatments and supports the structured protocol that has been followed for years in the Dr. Rife BeamRay protocol.
Over the course of 15 years, these frequencies, transmitted through light via the BeamRay Mats, have shown remarkable results in cancer treatments. Patients have experienced reductions in tumor size and other benefits as the frequencies interact with their cells at a deeply molecular level. Dr. Rife’s original idea of using electromagnetic frequencies to target and eliminate harmful cells has been further validated with continued advancements and refinements in the BeamRay system. As part of the BeamRay protocol, each frequency has a specific target in the body, corresponding to particular types of cancer, ensuring that the treatment is highly specialized to the patient’s needs.
The use of light as a transmission medium has proven particularly effective, as it allows for non-invasive and painless treatments. Patients can relax while the mats deliver the frequencies, which are absorbed through the skin. The interaction of the frequencies with the body’s natural electromagnetic fields creates a therapeutic effect, stimulating healing and offering an alternative approach to traditional cancer treatments. The effectiveness of the BeamRay Mats and their ability to address such a wide range of cancers has led many patients to seek out this non-invasive therapy as a complementary treatment alongside other medical interventions.
By following the Dr. Rife BeamRay protocol, which adheres to the careful selection and application of specific frequencies, the BeamRay Mats provide a modern, accessible way to continue the fight against cancer. These treatments are consistent with the original principles Dr. Rife set out in the early 20th century but have been refined and optimized with cutting-edge technology for the benefit of patients today. The BeamRay Mats, with their precise frequency transmission through light, continue to offer hope and healing, helping patients who may have otherwise exhausted traditional treatment options.
As Dr. Rife’s groundbreaking work continues to evolve through the BeamRay company, the legacy of his innovations lives on. The creation of Program #2 and its use in BeamRay Mats is just one more chapter in the story of how frequency-based treatments can be used to address the complex and often daunting challenge of cancer. With each successful treatment, the original vision of Dr. Rife is realized more fully, offering patients a chance for healing through the power of light and frequency.
Cancer Comprehensive group is general group for the treatment of
Adrenocortical Cancer, Bladder Cancer, Bone Cancer, Brain Tumor Cancer, Brain Stem Glioma Cancer, Cerebellar Astrocytoma Cancer, Cerebral Astrocytoma Cancer, Ependymoma Cancer, Medulloblastoma Cancer, S.P.N. & Pineal Tumors Cancer, Visual Pathway and Hypothalamic Glioma Cancer, Breast Cancer, Cervical / Uterus Cancer, Colon Cancer, Digestive System Cancer, Ear Cancer, Endocrine Gland Cancer, Endometrium Cancer, Esophageal Cancer, Ewings PNET Primitive Neuroectodermal Tumor Cancer, Extracranial Germ Cell Tumor Cancer, Extrahepatic Bile Duct Cancer, Eye Cancer, Gallbladder Cancer, Gastric Stomach Cancer, Gastrointestinal Cancer, Genital Female Cancer, Genital Male Cancer, Germ Cell Cancer, Gestational Tumor Cancer, Head and Neck Cancer, Hypopharyngeal Cancer, Intestinal Gastrointestinal Cancer, Islet Cell Carcinoma Cancer, Kidney Renal Cancer, Larynx Cancer, Leukemia Cancer, Leukemia Acute Myeloid Cancer, Leukemia Chronic Lymph Cancer, Leukemia Hairy Cell Cancer, Leukemia Lymphoblastic Cancer, Leukemia Myelogenous Cancer, Lip and Oral Cavity Cancer, Liver Cancer, Lung Non-Small Cell Cancer, Lung Small Cell Cancer, Lymphoma Cancer, Lymphoma B-Cell Cancer, Lymphoma Malignant Cancer, Lymphoma Non-Hodgkin Cancer, Lymphoma T-Cell Cancer, Lymphoplasmacytic Cancer, Malignant Mesothelioma Cancer, Melanoma Cancer, Merkel Cell Cancer, Metastasis Squamous Cancer, Mouth Cancer, Multiple Myeloma inc Plasma C Cancer, Mycosis Fungoides Cancer, Myelodysplastic Syndrome Cancer, Myeloproliferative Disorders Cancer, Nasopharyngeal Cancer, Nervous System Neoplasms Cancer, Neuroblastoma Cancer, Oral Cancer, Oropharyngeal Cancer, Otorhinolaryngologic Cancer, Ovarian Cancer, Ovarian Epithelial Cancer, Ovarian Germ Cell Cancer, Ovarian Low Malignant Potential Tumor Cancer, Pancreatic, Exocrine & Islet Cell Cancer, Paranasal Sinus and Nasal Cavity Cancer, Parathyroid Cancer, Penile [Penis] Cancer, Pheochromocytoma [Non-Benign] Cancer, Pituitary Cancer, Plasma Cell Neoplasm Cancer, Prostate Cancer, Rectal [Rectum] Cancer, Renal Cell [Kidney] Cancer, Residual Cancer, Respiratory Tract Cancer, Rhabdomyosarcoma Cancer, Salivary Gland Cancer, Sarcoma General Cancer, Sezary Syndrome Cancer, Skin Cancer, Skin Kaposi’s Sarcoma Cancer, Skin Melanoma Cancer, Skin T-Cell Lymph Cancer, Small Intestine Cancer, Soft Tissue Sarcoma Cancer, Squamous Cell Carcinoma Cancer, Stomach Cancer, Testicular [Testis] Cancer, Thoracic Cancer, Thymoma Cancer, Thyroid Cancer, Tonsil Cancer, Trophoblastic Cancer, Urethral [Urinary] Cancer, Urinary Bladder Cancer, Urologic Neoplasms Cancer, Uterine Sarcoma Cancer, Uterine Cervical Cancer, Vaginal Cancer, Vulvar Cancer, Wilms Tumor Cancer, Womb Cancer.
Conditions for Treatment with the BeamRay Light Mats
BeamRay Infrared Therapy Device
Supporting Recovery and Pain Relief with Advanced Infrared Technology for Cancer Care
5 Treatment Modes
● BeamRay™ Original
● Cancer Comprehensive
● Cancer Comp (Alternative Set)
● Cancer Metastasis
● Dr Rife’s Specialized MOR CW
Automatic Timer
Automatic timer permits 30,60,90 and 120 minutes
Comes with Adjustable Strap
The BeamRay device features an adjustable velcro strap, offering a universal fit that ensures the device stays comfortably and securely in place on any targeted area for all users.
BeamRay Therapy Device
Advanced BeamRay Technology for Cancer Care
Multiple BeamRay Light Mats
● BeamRay White Light Mat
● BeamRay Infrared Light Mat
Adjustable Intensity
Adjustable Intensity
Switch from low intensity to High intensity with the press of a button
140 Programmable Infrared LEDs
Each of the 140 LEDs on the BeamRay Mats operate on specialized frequency programs tailored to target specific Cancer sites, enhancing the effectiveness of treatment.
This powerful, BeamRay device is designed with 2 mat options. One mat features an array of Visible Infrared RED LED lights, with each mat containing 140 LEDs optimized for targeting cancers. The 2nd mat is a 140 LED White light mat with an array of White LEDs simulating the original Dr Rife BeamRay. Together, the LED lights work to target various cancer types and assist in treatment and recovery.
